Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 276

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

Open access
Donehower, L A, Godley, L A, Aldaz, C M, Pyle, R, Shi, Y P, Pinkel, D, Gray, J, Bradley, A, Medina, D, Varmus, H E·1995·Genes & Development

Abstract

By crossing mice that carry a null allele of p53 with transgenic mice that develop mammary adenocarcinomas under the influence of a Wnt-1 transgene, we have studied the consequences of p53 deficiency in mammary gland neoplasia. In Wnt-1 transgenic mice homozygous for the p53 null allele, tumors appear at an earlier age than in animals heterozygous or wild-type at the p53 locus. About half of the tumors arising in p53 heterozygotes exhibit loss of the normal p53 allele, implying selection for p53-deficient cells. Mammary tumors lacking p53 display less fibrotic histopathology and increased genomic instability with aneuploidy, amplifications, and deletions, as detected by karyotype analysis and comparative genomic hybridization. In one tumor, the amplified region of chromosome 7 had an ectopically expressed int-2/FGF3 proto-oncogene, a gene known to cooperate with Wnt-1 in the production of mammary tumors. These findings favor a model in which p53 deficiency relaxes normal restraints on chromosomal number and organization during tumorigenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.9.7.882

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 51

  1. 1992, Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression., Cancer Res., 52, 4791
  2. 1989, Molecular cloning and chromosomal mapping of DNA rearranged with parathyroid hormone gene in a parathyroid adenoma., J. Clin. Invest, 83, 2034, 10.1172/JCI114114 · DOI
  3. 10.1016/0092-8674(86)90779-8 · DOI · Paper page
  4. 1990, Spontaneous immortalization of normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization., Cancer Res., 50, 7979
  5. 10.1093/jnci/84.11.826 · DOI
  6. 1993, Transgenic models of mammary tumorigenesis., Cancer Surv., 16, 97
  7. 1994, Molecular dissection of multi-stage tumorigenesis in transgenic mice., Sem. Cancer Biol., 5, 3
  8. 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways., Nature, 352, 849
  9. 1984, The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes., Mol. Cell. Biol., 4, 1638
  10. 10.1126/science.7521539 · DOI · Paper page
  11. 10.1016/0092-8674(93)90484-8 · DOI · Paper page
  12. 10.1073/pnas.83.13.4834 · DOI · Paper page
  13. 10.1016/0092-8674(90)90186-I · DOI · Paper page
  14. 10.1016/0092-8674(94)90187-2 · DOI · Paper page
  15. 1994, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis., Cancer Res., 54, 4855
  16. 1993, Genetic background alters the spectrum of tumors that develop in p53-deficient mice., FASEB J., 7, 938, 10.1096/fasebj.7.10.8344491 · DOI · Paper page
  17. 1993, In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice., Oncogene, 8, 2457
  18. 1994, Tumor spectrum analysis in p53-mutant mice., Curr. Biol., 4, 1, 10.1016/S0960-9822(00)00002-6 · DOI · Paper page
  19. 10.1126/science.1359641 · DOI · Paper page
  20. 10.1016/0092-8674(91)90033-U · DOI · Paper page
  21. 1991, Participation of p53 protein in the cellulary response to DNA damage., Cancer Res., 51, 6304
  22. 10.1016/0092-8674(93)90461-X · DOI · Paper page
  23. 10.1126/science.256.5058.827 · doi:10.1126/science.256.5058.827 · Paper page
  24. 1992, Transgenes expressing the Wnt-1 and int-2 protooncogenes cooperate during mammary carcinogenesis in doubly transgenic mice., Mol. Cell. Biol., 12, 147
  25. 1991, D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1., Oncogene, 6, 439
  26. 1989, High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene., Mol. Cell. Biol., 9, 3982
  27. 1988, Amplification of the int-2 gene in primary human breast tumors., Oncogene Res., 2, 285
  28. 10.1016/0092-8674(92)90243-6 · DOI · Paper page
  29. 10.1016/0092-8674(93)90719-7 · DOI · Paper page
  30. 10.1126/science.7973635 · DOI · Paper page
  31. 10.1016/0092-8674(93)90496-D · DOI · Paper page
  32. 1988, Four classes of mRNA are expressed from the mouse int-2 gene, a member of the FGF gene family., EMBO J., 7, 2035, 10.1002/j.1460-2075.1988.tb03043.x · DOI
  33. 1973, Preneoplastic lesions in mouse mammary tumorigenesis., Methods Cancer Res., 7, 3
  34. 1978, Enhancement of the tumorigenicity of preneoplastic mammary lines by enzymatic dissociation., J. Natl. Cancer Inst., 60, 1121, 10.1093/jnci/60.5.1121 · DOI
  35. 1994, p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia., Gastroenterology, 106, 1589, 10.1016/0016-5085(94)90415-4 · DOI
  36. 10.1016/0092-8674(94)90188-0 · DOI · Paper page
  37. 10.1038/320628a0 · DOI
  38. 10.1073/pnas.86.15.5678 · DOI · Paper page
  39. 10.1002/cyto.990190104 · doi:10.1002/cyto.990190104
  40. 1994, Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene., Oncogene, 9, 603
  41. 1984, Chromosomal assignment of the murine gene encoding the transformation-related protein p53., Mol. Cell. Biol., 4, 383
  42. 1979, Classification of mouse mammary tumors in Dunn's miscellaneous group, including recently reported types., J. Natl. Cancer Inst., 62, 1287
  43. 10.1073/pnas.90.2.740 · DOI
  44. 10.1126/science.8456283 · DOI · Paper page
  45. 10.1126/science.3798106 · DOI · Paper page
  46. 10.1038/348747a0 · DOI · Paper page
  47. 1987, Definition of regions in human c-myc that are involved in transformation and nuclear localization., Mol. Cell. Biol., 7, 1697
  48. 10.1093/jnci/84.11.845 · DOI · Paper page
  49. 10.1016/0092-8674(88)90220-6 · DOI · Paper page
  50. 10.1016/0092-8674(92)90244-7 · DOI · Paper page
  51. 10.1038/352345a0 · DOI · Paper page

Cited by

See all 276

Metadata

Authors
Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E.
Venue
Genes & Development
Published
1995-04-01
Volume
9
Issue
7
Pages
882-895
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2143324424
Cited by
276
References
8
Type
posted content
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. https://app.cochat.ai/papers/10.1101/gad.9.7.882
The paper
Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E. (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes & Development. https://doi.org/10.1101/gad.9.7.882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.